The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...
An unlicensed driver who drove drunk causing a deadly collision in Rexdale two years ago has been sentenced to four years in ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis ...
InvestorsHub on MSN
Tvardi Therapeutics Stock Plunges 30% After Disappointing IPF Trial Results
Shares of Tvardi Therapeutics (NASDAQ:TVRD) dropped 30% on Monday after the company released weak preliminary results from ...
Generic Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ...
Nerandomilast, marketed as Jascayd by its manufacturer Boehringer Ingelheim, is the first therapy approved in more than 10 ...
The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback